CHARLOTTE, N.C., June 6, 2025 – Honeywell (NASDAQ: HON) today announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around the world receive the life-saving medications they need in secure packaging while supporting the industry’s efforts to shift toward recyclable solutions.1
Honeywell Aclar film is a medical grade material that can be used for both rigid and flexible packaging solutions. It helps protect the efficacy of prescription and over the counter (OTC) medication by providing the best moisture barrier polymer available for drug stability. This can help extend shelf life and reduce waste in the pharmaceutical industry. Further, unique technical production methods make it easy to separate and recycle Aclar films.2
Evertis, through its Evercare brand, will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries due to its lightweight and versatile nature. By using Aclar films in its PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.
“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging. By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar® barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties - while also meeting sustainability credentials,” said Casimiro Sacchetti, CSO of Evertis Americas.
“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare,” said Jeff Dormo, President of Sustainability and Decarbonization, Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
Honeywell will work with Evertis to help support the design, development and launch of new packaging materials. The PET products are expected to be on the market in 2025.
Honeywell’s Advanced Materials business will be renamed Solstice Advanced Materials after a tax-free spin-off to shareholders, expected to take place by early 2026. The new company will be based in Morris Plains, New Jersey. The independent company will specialize in chemicals and materials, offering leading technologies in premier brands including refrigerants, liquid blowing agents, medical and pharmaceutical packaging and semiconductor components.
Learn more about Honeywell’s comprehensive range of Aclar products here and Evercare’s portfolio here.
###
About Honeywell
Honeywell is an integrated operating company serving a broad range of industries and geographies around the world. Our business is aligned with three powerful megatrends – automation, the future of aviation and energy transition – underpinned by our Honeywell Accelerator operating system and Honeywell Forge IoT platform. As a trusted partner, we help organizations solve the world's toughest, most complex challenges, providing actionable solutions and innovations through our Aerospace Technologies, Industrial Automation, Building Automation and Energy and Sustainability Solutions business segments that help make the world smarter and safer as well as more secure and sustainable. For more news and information on Honeywell, please visit www.honeywell.com/newsroom.
About Evertis
Evertis, present in the polymers industry since 1959 and pioneers in PET film extrusion, is a specialist in the production of barrier films for food packaging, and other packaging applications.
With a wide variety of tailor-made solutions in their portfolio, Evertis focuses on supplying films that ensure product safety whilst closing the loop. Evertis envisions a future with increased utilization of recycled content in their films, greater recyclability of their products and the lowest feasible carbon footprint.
Being a global business, with manufacturing sites in Portugal, Brazil, Italy and Mexico, Evertis is devoted to playing a role in society’s collective response to the global plastic waste challenge, through recycling education programs as well as jointly working across the value chain to create tangible solutions. Their mission is to develop future-fit packaging that meets the highest expectations of clients and end consumers in terms of food safety, functionality and circularity. www.evertis.com
About Evercare™
Evercare™ provides the healthcare industry with an extensive portfolio of specialty and innovative medical-grade films designed to provide superior performance and support regulatory compliance.
Our innovative polyester (PET and PETG) based solutions offer performance and sustainability advantages when compared to other materials. Evercare™ films facilitate the thermoforming process, provide improved mechanical and optical properties, and have a better resistance to sterilization. Additionally, our EvercareTM films can incorporate advanced chemical recycled content to help you meet your sustainability goals without sacrificing quality and regulatory.
Our films are manufactured in strict compliance with GMP standards, with a track record of 65+ years developing polyester films for regulated applications.
To support your regulatory compliance needs, Evercare™ films are offered with declarations such as ISO10993, USP661.1, ISO11607, as well as change notification. For more information visit www.evertis-evercare.com.
1 https://ess.honeywell.com/us/en/about-ess/newsroom/featured-stories/the-importance-of-collaboration-in-tackling-sustainability-in-pharma and Sustainable Medicines Partnership
